Abstract:Interleukin-1 (IL-1) signaling is essential for controlling virulent Mycobacterium tuberculosis ( Mtb ) infection since antagonism of this pathway leads to exacerbated pathology and increased susceptibility. In contrast, the triggering of type I interferon (IFN) signaling is associated with the progression of tuberculosis (TB) disease and linked with negative regulation of IL-1 signaling. However, mice lacking IL-1 signaling can control Mtb infection if infected with an Mtb strain carrying the rifampin-resistance conferring mutation H445Y in its RNA polymerase β subunit ( rpoB -H445Y Mtb ). The mechanisms that govern protection in the absence of IL-1 signaling during rpoB -H445Y Mtb infection are unknown. In this study, we show that in the absence of IL-1 signaling, type I IFN signaling controls rpoB -H445Y Mtb replication, lung pathology, and excessive myeloid cell infiltration. Additionally, type I IFN is produced predominantly by monocytes and recruited macrophages and acts on LysM-expressing cells to drive protection through nitric oxide (NO) production to restrict intracellular rpoB -H445Y Mtb . These findings reveal an unexpected protective role for type I IFN signaling in compensating for deficiencies in IL-1 pathways during rpoB -H445Y Mtb infection. Mycobacterium tuberculosis ( Mtb ) is the causative agent of tuberculosis (TB) and is responsible for 10 million active cases worldwide annually. The acquisition and dissemination of drug resistance to front-line antibiotics have stifled efforts to control and combat TB. Understanding the immune responses elicited during Mtb infection is imperative to develop novel therapeutics that bolster protective responses and limit detrimental processes. Recently, we found that mice do not require the inflammatory interleukin-1 (IL-1) signaling pathway to control Mtb infection if the infecting bacterial strains carry a specific drug resistance-conferring mutation. Instead, here we show that a different signaling pathway, type I interferon (IFN), mediates protection against drug-resistant mutant Mtb infection in the absence of IL-1 signaling. We also found that the primary producers of type I IFN during drug-resistant Mtb infection were recruited innate cells, namely monocytes and macrophages. The downstream impacts of IFN signals were varied, with macrophages restricting bacterial replication while other immune cell functions were likely impaired by IFN signaling. Our study provides new insights into the different host requirements for protection against infection by various Mtb strains and highlights the unexpected roles for type I IFN signaling during Mtb infection.

NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis

ROLE OF TOLL-LIKE RECEPTORS SENSING AND CONTROL OFMYCOBACTERIAL INFECTION

NOD2 enhances the innate response of alveolar macrophages to Mycobacterium tuberculosis in humans

Mycobacterium tuberculosis Induces Irg1 in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis

A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y

Innate Immunity to Mycobacterial Infection in Mice: Critical Role for Toll-Like Receptors

Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium Tuberculosis Infection

The integrated stress response mediates type I interferon driven necrosis in Mycobacterium tuberculosis granulomas

Deficiency of the AIM2–ASC Signal Uncovers the STING-Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN-γ Immunity in Mycobacterial Infection

Mycobacterium tuberculosis inhibits autocrine type I interferon signaling to increase intracellular survival

Partial Redundancy of the Pattern Recognition Receptors, Scavenger Receptors, and C-Type Lectins for the Long-Term Control of<i>Mycobacterium</i><i>tuberculosis</i>Infection

Type I IFN signaling mediates NET release to promote Mycobacterium tuberculosis replication and granuloma caseation

The Mechanism for Type I Interferon Induction by Mycobacterium tuberculosis is Bacterial Strain-Dependent

Type I IFN signaling in the absence of IRGM1 promotes M. tuberculosis replication in immune cells by suppressing T cell responses

Partial Redundancy of the Pattern Recognition Receptors, Scavenger Receptors, and C-Type Lectins for the Long-Term Control of Mycobacterium Tuberculosis Infection

Prominent Role for T Cell-Derived Tumour Necrosis Factor for Sustained Control of Mycobacterium Tuberculosis Infection

Type I interferon responses contribute to immune protection against mycobacterial infection

An Interferon-Related Signature in the Transcriptional Core Response of Human Macrophages to Mycobacterium Tuberculosis Infection.

Regulation of Type I Interferon and Autophagy in Immunity against Mycobacterium Tuberculosis: Role of CGAS and STING1.

Interferon Regulatory Factor 1 Eliminates Mycobacteria by Suppressing P70 S6 Kinase Via Mechanistic Target of Rapamycin Signaling.